CoChat

Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency

Yuen, Kevin C. J., Frystyk, Jan, White, Deborah K., Twickler, Th. B., Koppeschaar, Hans P. F., Harris, Philip E., Fryklund, Linda, Murgatroyd, Peter R., Dunger, David B. · 2005 · Clinical Endocrinology
Cited by 67

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Summary: Objective Untreated GH‐deficient adults are predisposed to insulin resistance and excess cardiovascular mortality. We showed previously that short‐term treatment with a very low GH dose (LGH) enhanced insulin sensitivity in young healthy adults. The present study was therefore designed to explore the hypothesis that LGH, in contrast to the standard GH dose titrated to normalize serum IGF‐I levels (SGH), may have differing effects on insulin sensitivity, body composition, and cardiovascular risk markers [lipid profile, C‐reactive protein (CRP), interleukin‐6 (IL‐6), tumour necrosis factor‐α (TNF‐α) and adiponectin] in adults with severe GH deficiency. Patients and methods In this 12‐month open, prospective study, 25 GH‐deficient adults were randomized to receive either a fixed LGH (0·10 mg/day, n = 13) or SGH (mean dose 0·48 mg/day, n = 12), and eight age‐ and body mass index (BMI)‐matched GH‐deficient adults acted as untreated controls. Fasting blood samples were collected at baseline and at months 1, 3, 6, 9 and 12. Assessments of insulin sensitivity, using the hyperinsulinaemic euglycaemic clamp technique, and body composition, using dual‐energy X‐ray absorptiometry, were performed at baseline and at month 12. Results The LGH decreased fasting glucose levels (P < 0·01) and enhanced insulin sensitivity (P < 0·02), but body composition, nonesterified fatty acid (NEFA) levels and cardiovascular risk markers were unchanged. The SGH did not modify insulin sensitivity, decreased truncal fat mass (P < 0·05), CRP (P < 0·05) and IL‐6 (P < 0·05) levels, and increased NEFA levels (P < 0·05). No changes were observed with the untreated controls. Conclusion Our data indicate that, in contrast to the SGH, fixed administration of the LGH enhances insulin sensitivity with no apparent effects on body composition, lipolysis and other surrogate cardiovascular risk markers in adults with severe GH deficiency. Thus, the LGH may potentially be a beneficial replacement dose in reducing type 2 diabetes risk in adults with severe GH deficiency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2005.02359.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 67

Metadata

Authors
Yuen, K. C. J., Frystyk, J., White, D. K., Twickler, T. B., Koppeschaar, H. P. F., Harris, P. E., Fryklund, L., Murgatroyd, P. R., & Dunger, D. B.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2005-09-03
Volume
63
Issue
4
Pages
428-436
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2108566143
Cited by
67
References
7
FWCI
4.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. https://app.cochat.ai/papers/10.1111/j.1365-2265.2005.02359.x
The paper
Yuen, K. C. J., Frystyk, J., White, D. K., Twickler, T. B., Koppeschaar, H. P. F., Harris, P. E., Fryklund, L., Murgatroyd, P. R., & Dunger, D. B. (2005). Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2005.02359.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.